Results 191 to 200 of about 1,438,452 (291)
Biatrial Thrombus Crossing Foramen Ovale in a Patient with Atrial Fibrillation. [PDF]
Javadova S +5 more
europepmc +1 more source
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler +8 more
wiley +1 more source
Nr2f1a and Isl1 repress acquisition of epicardial identity in venous atrial cardiomyocytes. [PDF]
Martin KE +6 more
europepmc +1 more source
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro +15 more
wiley +1 more source
The Circuit That Survived the Hurt and the One That Didn't! [PDF]
Anand AB, Gujral JS.
europepmc +1 more source
The Role of MYH6 Variants in atrial cardiomyopathy: insights from clinical observations and zebrafish models. [PDF]
Zhang Y +10 more
europepmc +1 more source
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia +2 more
wiley +1 more source
Prenatal diagnosis of a congenital pseudoaneurysm of the mitral-aortic intervalvular fibrosa: a multimodality imaging case report. [PDF]
Dorsi M +4 more
europepmc +1 more source
Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo +7 more
wiley +1 more source
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller +8 more
wiley +1 more source

